Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (341)	6/9/1998 2:31:00 AM
From: OLD JAKE JUSTUS	Respond to of 4891

TO: ALL I certainly do agree with a report that stated that Argentina approval is the big thing that we should be awaiting. Approval of Reticulose, in Argentina will, in my opinion, lead to a "Free Sales Certificate" from that country. This will open up Commercial Sales, of Reticulose, for the first time ever. Commercial sales in Argentina will ultimately open the door for commercial sales, of Reticulcose, in many other countries. Commercial sales of Reticulose should begin shortly after the approval of Reticulose, in Argentina! What was the problem that was allegedly straightened out in Argentina, recently? Does anyone know about it?